{"id":"https://openalex.org/W2371638215","doi":null,"title":"Memantine in the treatment of patients with moderate to severe Alzheimer disease","display_name":"Memantine in the treatment of patients with moderate to severe Alzheimer disease","publication_year":2010,"publication_date":"2010-01-01","ids":{"openalex":"https://openalex.org/W2371638215","mag":"2371638215"},"language":"en","primary_location":{"id":"mag:2371638215","doi":null,"is_oa":false,"landing_page_url":"https://en.cnki.com.cn/Article_en/CJFDTOTAL-ZNYX201004022.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764436401","display_name":"Central South Pharmacy","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Central South Pharmacy","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079394714","display_name":"Sufen Chen","orcid":"https://orcid.org/0000-0001-8453-0225","observed_orcids":["https://orcid.org/0000-0001-8453-0225"]},"institutions":[{"id":"https://openalex.org/I4210150657","display_name":"Chenzhou First People's Hospital","ror":"https://ror.org/04y2bwa40","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210150657"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Sufen Chen","raw_affiliation_strings":["Departmenr of Neurology,The First People's Hospital of Chenzhou,Chenzhou Hunan 423000)"],"raw_orcid":"https://orcid.org/0000-0001-8453-0225","affiliations":[{"raw_affiliation_string":"Departmenr of Neurology,The First People's Hospital of Chenzhou,Chenzhou Hunan 423000)","institution_ids":["https://openalex.org/I4210150657"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5079394714"],"corresponding_institution_ids":["https://openalex.org/I4210150657"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.33718074,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.40799999237060547,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.40799999237060547,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.392300009727478,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.18860000371932983,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/memantine","display_name":"memantine","score":1.0},{"id":"https://openalex.org/keywords/donepezil","display_name":"donepezil","score":0.9290000200271606},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9919999837875366},{"id":"https://openalex.org/keywords/clinical-efficacy","display_name":"clinical efficacy","score":0.6949999928474426},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.9850000143051147},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8579999804496765},{"id":"https://openalex.org/keywords/cognitive-function","display_name":"cognitive function","score":0.6259999871253967},{"id":"https://openalex.org/keywords/activities-of-daily-living","display_name":"activities of daily living","score":0.8960000276565552},{"id":"https://openalex.org/keywords/nmda-receptor-antagonist","display_name":"NMDA receptor antagonists","score":0.7400000095367432}],"concepts":[{"id":"https://openalex.org/C2779484449","wikidata":"https://www.wikidata.org/wiki/Q412189","display_name":"Memantine","level":4,"score":0.9858019948005676},{"id":"https://openalex.org/C2780904820","wikidata":"https://www.wikidata.org/wiki/Q415081","display_name":"Donepezil","level":4,"score":0.9648504853248596},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6538199186325073},{"id":"https://openalex.org/C2776000289","wikidata":"https://www.wikidata.org/wiki/Q5133761","display_name":"Clinical Global Impression","level":4,"score":0.6083993315696716},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5914573073387146},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5601969361305237},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.4779805541038513},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.474489688873291},{"id":"https://openalex.org/C2779077818","wikidata":"https://www.wikidata.org/wiki/Q913257","display_name":"Mini\u2013Mental State Examination","level":4,"score":0.46004584431648254},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.33353060483932495},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.2942209243774414},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.07050776481628418},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2371638215","doi":null,"is_oa":false,"landing_page_url":"https://en.cnki.com.cn/Article_en/CJFDTOTAL-ZNYX201004022.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764436401","display_name":"Central South Pharmacy","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Central South Pharmacy","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2348965976","https://openalex.org/W2380631247","https://openalex.org/W2132806643","https://openalex.org/W2102526426","https://openalex.org/W2352194267","https://openalex.org/W2351811147","https://openalex.org/W277713272","https://openalex.org/W2374607623","https://openalex.org/W3030014596","https://openalex.org/W2372677308"],"abstract_inverted_index":{"Objective":[0],"To":[1],"evaluate":[2],"the":[3,11,65,78,97,103,112,115,122,129,133,148,173],"clinical":[4],"efficacy":[5,60],"and":[6,77,109,135,139,154],"safety":[7],"of":[8,13,23,41,47,74,91,101,107,124,147],"memantine":[9,48,130,149],"in":[10,88,99,105,114,121,128,145],"treatment":[12],"patients":[14,25,163],"with":[15,26,111,164],"moderate":[16,27,165],"to":[17,28,86,166],"severe":[18,29,167],"Alzheimer":[19,69,92,168],"disease(AD).Methods":[20],"A":[21],"total":[22],"100":[24],"AD":[30],"were":[31,143],"randomly":[32],"divided":[33],"into":[34],"2":[35],"groups,who":[36],"respectively":[37],"received":[38],"10":[39],"mg":[40,46],"donepezil":[42,87,116,161],"daily":[43,49],"or":[44],"20":[45],"for":[50,162],"16":[51],"weeks.Clinical":[52],"evaluation":[53],"was":[54,61,118],"conducted":[55],"every":[56],"4":[57],"weeks.The":[58],"primary":[59],"evaluated":[62],"by":[63,96],"using":[64],"Mini-Mental":[66],"Status":[67],"Examination(MMSE),the":[68],"Disease":[70],"Assessment":[71],"Scale-cognition(ADAS-cog),the":[72],"Activities":[73],"Daily":[75],"Living(ADL)":[76],"Clinical":[79],"Global":[80],"Impression(CGI).Results":[81],"Memantine":[82,151],"had":[83],"similar":[84,158],"efficacies":[85],"improving":[89],"symptoms":[90],"disease":[93],"as":[94,160],"evidenced":[95],"increase":[98],"scores":[100,106],"MMSE,and":[102],"decrease":[104],"ADAS-cog":[108],"ADL(P0.05).Compared":[110],"data":[113],"group,there":[117],"no":[119],"significance":[120],"change":[123],"these":[125],"measuring":[126],"scales":[127],"group":[131],"before":[132],"therapy":[134],"at":[136],"16th":[137],"week(P0.05).Mild":[138],"transient":[140],"adverse":[141],"events":[142],"observed":[144],"5%":[146],"group.Conclusion":[150],"is":[152],"safe":[153],"effective,which":[155],"has":[156],"a":[157],"effect":[159],"disease(AD),and":[169],"can":[170],"remarkably":[171],"improve":[172],"symptoms.":[174]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}